Ultigo 4mg Tablet MD

Visão geral do produto

About Ultigo

Ultigo is a medication containing the active ingredient Ondansetron, classified as Medication to prevent nausea and vomiting. Ondansetron, sold under the brand name Zofran among others, is a medication used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, migraines, or surgery. It is also effective for treating gastroenteritis.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer.
• Used for: initial and repeat courses of moderately emetogenic cancer chemotherapy
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Ondansetron, the active ingredient in Ultigo, belongs to the Medication to prevent nausea and vomiting class. 1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to /m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Ultigo. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Ultigo for extended periods without medical advice.